Skip to search formSkip to main contentSkip to account menu

Auranofin

Known as: (1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate, 2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold, Auranofin [Chemical/Ingredient] 
An orally available, lipophilic, organogold compound, used to treat rheumatoid arthritis, with anti-inflammatory and potential antineoplastic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Drug discovery, development and registration is an expensive and time-consuming process associated with a high failure rate… 
Highly Cited
2015
Highly Cited
2015
Significance The identification of new antibiotics with novel mechanisms of action has become a pressing need considering the… 
Highly Cited
2014
Highly Cited
2014
Chronic lymphocytic leukemia (CLL) exhibits high remission rates after initial chemoimmunotherapy, but with relapses with… 
Highly Cited
2010
Highly Cited
2009
Highly Cited
2009
Schistosomiasis is a parasitic disease affecting over 200 million people currently treated with one drug, praziquantel. A… 
Highly Cited
2002
Highly Cited
2002
Gold(I)‐thiolate drugs are compounds that specifically interact with thiol and/or selenol groups and are essentially utilized in… 
Highly Cited
1985
Highly Cited
1985
The coordinated gold compound, 2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S-triethyl phosphine gold (auranofin; Ridaura… 
Highly Cited
1976
Highly Cited
1976
Eight patients with rheumatoid arthritis were treated with SK & F D-39162 (auranofin), a new oral gold compound which was…